Long-Term Effectiveness of Balloon Catheter Sinuplasty in Pediatric Chronic Maxillary Sinusitis by Zalxal, Habib G. et al.
Faculty & Staff Scholarship 
2019 
Long-Term Effectiveness of Balloon Catheter Sinuplasty in 
Pediatric Chronic Maxillary Sinusitis 
Habib G. Zalxal 
Chadi A. Makary 
Hassan Ramadan 
Follow this and additional works at: https://researchrepository.wvu.edu/faculty_publications 
 Part of the Surgery Commons 
Clinical Study
Long-Term Effectiveness of Balloon
Catheter Sinuplasty in Pediatric
Chronic Maxillary Sinusitis
Habib G. Zalzal, MD1, Chadi A. Makary, MD1,
and Hassan H. Ramadan, MD, MSc, FACS1
Abstract
The objective of our study was to assess the long-term effectiveness of balloon catheter sinuplasty in the treatment of pediatric
chronic maxillary sinusitis following failed first-line medical and surgical management with adenoidectomy. Pediatric patients
younger than 12 years were reviewed for having failed previous adenoidectomy and undergone a balloon catheter sinuplasty
between August 2006 and March 2011 for chronic rhinosinusitis. Demographic data and clinical characteristics were recorded in
patients who met inclusion criteria. Outcomes were assessed by need for functional endoscopic sinus surgery and persistence of
chronic infection within at least 5 years of follow-up. Failure was defined by any child who was rediagnosed with chronic sinus
disease after balloon catheter sinuplasty or who required endoscopic sinus surgery within 5 years. Sixty-two children were
reviewed, with 38 patients meeting inclusion criteria (prior adenoidectomy, a preoperative Lund-Mackay score of5, and balloon
catheter sinuplasty). The mean age (standard deviation) was 6.76 (2.27) years with an age range of 2 to 11 years. Eight children
(21.1%, P < .01) continued to have chronic sinus complaints following balloon procedure, with 5 (13.1%) individuals requiring
eventual endoscopic surgery within 5 years. Age, asthma, allergy, and gender did not have any statistically significant impact on
outcome. Balloon catheter sinuplasty is an effective long-term alternative for the treatment of chronic rhinosinusitis in pediatric
patients, hoping to avoid further infections and eventual endoscopic surgery.
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Introduction
Chronic rhinosinusitis (CRS) is one of the most common dis-
eases afflicting the general population, estimated to affect up to
12% of the population in the United States.1 Nearly $1.8 billion
is spent on treating CRS in children younger than 12 years
annually.1 Pediatric CRS may start as a childhood viral upper
respiratory tract infection initially, but up to 13% of these
patients may have symptoms that progress to a chronic dis-
ease.2 A majority of children will improve with medical ther-
apy, such as oral antibiotics, allergy therapy, nasal saline
irrigations, topical nasal steroids, and asthma control.3 How-
ever, when symptoms continue despite maximal medical man-
agement, surgical intervention is indicated.2
Current clinical guidelines recommend that adenoidectomy
is the first-line surgical intervention for children with CRS.3
However, even with adenoidectomy, sinus disease may persist
in up to 50% of cases.4 Success rate of first-line adenoidectomy
declines even further with the presence of asthma in children
aged 6 years or younger.5 For patients who have failed both
medical management and adenoidectomy, functional endo-
scopic sinus surgery (FESS) has been shown to be an effective
next-step procedure for treating CRS.2 In fact, in some cases,
FESS is more effective than adenoidectomy alone for some
patients with complicated sinus disease.5 However, it can be
technically difficult and has the potential for serious
complications.6
First described in the early 2000s, balloon catheter sinu-
plasty (BCS) has been shown to be an available treatment
modality for pediatric CRS. However, its proven role in treat-
ing disease has not yet been elucidated.2 In 2012, our institution
looked at the success rate of BCS in the first year and found that
81% of children achieved significant symptomatic improve-
ment based on the SN-5 questionnaire.7 In this study, we eval-
uated the long-term effectiveness of BCS in the treatment of
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pediatric CRS following failed first-line surgical management
with adenoidectomy. Currently, the most recently clinical
consensus statements suggest that an FESS be performed after
failure to control sinus disease with adenoidectomy.2 Our aim
is to assess the utility of BCS as a long-term, less invasive
alternative to FESS for resolution of chronic disease in the
hopes that endoscopic surgery can be avoided in the pediatric
population.
Patients and Methods
This study was performed at a large, academic tertiary care
facility, following institutional review board approval. A com-
putational search of all pediatric patients referred to the otolar-
yngology clinic for CRS was performed. Search was limited to
patients younger than 13 years from August 2006 to March
2011. All patients were managed by the same attending otolar-
yngologist. As per recent guidelines, CRS was defined by at
least 90 continuous days of 2 or more symptoms of purulent
rhinorrhea, nasal obstruction, facial pressure, cough, or endo-
scopic signs of mucosal edema, purulence, or polyposis.2,8 To
have been considered for balloon sinuplasty, patients would
have had to have failed maximal medical therapy as defined
by the European Position Paper on Rhinosinusitis and Nasal
Polyps, which endorses 3 to 4 weeks of oral or intravenous
antibiotics, topical nasal steroid sprays, and allergy manage-
ment when appropriate.8
This subset of patients was further reviewed to include only
those who (1) previously underwent adenoidectomy, (2) had a
computed tomography (CT) scan performed of their sinuses
prior to BCS, and (3) were available for follow-up for at least
5 years postoperatively. Patients who were asymptomatic for at
least 3 years postoperatively were discharged from clinic but
still eligible as long as they did not return for sinus complaints
within 5 years of BCS. The CT scans of the sinuses were graded
using the Lund-Mackay system by the senior author.9 Only
children with a Lund-Mackay score of 5 were included, as
this is consistent with a diagnosis of CRS that is unlikely to be
controlled by adenoidectomy alone.10 Most children had at
least unilateral or bilateral maxillary sinus disease, although
some had additional ethmoid disease that was not addressed
at the time of BCS. Each BCS was performed following pos-
itive maxillary sinus disease on CT scan prior to surgery with
diagnostic criteria for CRS. Exclusion criteria included chil-
dren having underlying conditions predisposing for CRS,
including immunodeficiency disorders, ciliary motility disor-
ders, or cystic fibrosis.
Data extracted from the available notes within the electronic
medical record included the following: gender, birthdate, prior
adenoidectomy, prior CT scan, date of BCS, office visits for
monitoring of sinus infections, number of antibiotic treatments
required post-BCS, and subsequent surgeries after initial BCS
with associated age and time frame between surgeries. Addi-
tional data into past medical history looking at asthma, aller-
gies/allergic rhinitis, and aforementioned congenital
immunodeficiency were also recorded. Diagnosis of medical
conditions (allergies, asthma, etc) was based on their presence
either in the medical notation by the treating otolaryngologist
or within the medical record via International Classification of
Diseases, Ninth Revision codification at the time of BCS.
For all patients included in this study, BCS was performed
by the senior author in the following manner under general
anesthesia. The nasal passage was decongested with
oxymetazoline-soaked pledgets. Under direct visualization
through a rigid endoscope, the sinus guide catheter was inserted
behind the uncinate process. A flexible guidewire was passed
through the catheter into the maxillary sinus. Confirmation that
the guidewire was in the sinus was made with fluoroscopy or
transillumination. The sinus balloon catheter was passed over
the guidewire into the sinus and placed across the ostium. After
positioning was confirmed, the balloon was inflated, thereby
enlarging the natural ostium. The BCS was performed either to
one maxillary sinus or bilaterally to both sinuses depending on
the CT scan findings.
The children were followed at 3- to 6-month intervals post-
BCS for up to 5 years. At each clinical visit, the patient or
caregiver was asked about the major symptoms of nasal
obstruction or stuffiness, yellow/green rhinorrhea, or postna-
sal discharge, cough, and facial pain or headache since their
last visit. In addition, questions involving diagnosed sinus
infection or need for antibiotic prescription for sinus disease
were also documented. The questions were subjective
because, when the study was initiated, no validated chronic
sinusitis instruments were available for use. Any child who
had documented sinus infections requiring antibiotics more
than 5 times within a 12-month period (whether for acute
recurrent or solitary recalcitrant sinus infections), who was
rediagnosed with CRS as defined by the European Guide-
lines,8 or who required an FESS was considered a treatment
failure if the event occurred within 5 years of the initial BCS.
Patients who met criteria to have subsequent endoscopic sinus
surgery, but did not due to parental decision-making, were
also considered for failure criteria.
Statistical evaluation was executed using IBM SPSS Statis-
tics (version 24.0; IBM Corp, Armonk, New York) software.
Failure criteria were analyzed using binomial significance test-
ing, with a null test statistic for BCS set at 0.99. This test
statistic was utilized as it is consistent with the clinical consen-
sus that an FESS would otherwise be performed in CRS
patients who failed medical management and prior adenoidect-
omy. Any success expected from BCS in preventing FESS in
pediatric patients would counter current recommended guide-
lines, so a null test statistic for failure would be expected at
0.99. w2 analysis was performed for nominal data with Pearson
correlation, while independent samples t tests were performed
for interval data (time between procedures and age character-
istics). Statistical significance was defined as P  .05.
Results
A total of 62 children initially met initial criteria for having
undergone a BCS at our institution. After excluding patients
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who did not have a prior adenoidectomy and had a Lund-
Mackay score <5, 38 patients (age range: 2-11 years old) met
the inclusion criteria for our study. Table 1 summarizes the
demographic and operative characteristics of these patients.
Mean age (standard deviation [SD]) at the time of BCS was
6.76 (2.27) years. Male children (22; 57.8%) outnumbered
females (16; 42.2%) in this patient population. Allergic rhinitis
(15; 39.4%) and asthma (13; 34.2%) were also prevalent among
these patients. The mean CT Lund-MacKay score was 8.63
(3.47) in all patients undergoing BCS, with 11 patients
(28.9%) having findings indicative of ethmoid disease. The
average time of follow-up was 3.84 years post-BCS.
Overall, BCS was a long-term success for 30 (78.9%)
patients in preventing further sinus infections and subsequent
sinonasal surgery. Eight (21.1%) children met failure criteria
within 5 years after BCS due to continued symptoms of CRS
despite medical therapy (P < .01). Of these 8 patients,
5 (13.1%) children underwent subsequent FESS to control
their symptoms of CRS. The average time (SD) to surgical
failure, that is, requiring FESS, was 2.18 (1.44) years. The
mean CT Lund-MacKay score for patients who failed BCS
was 7.87 (2.45).
Fortunately, 33 (86.9%) patients were able to avoid having
further surgery within 5 years of their balloon procedure,
although 3 did not meet success criteria due to subsequent
infections. The majority of patients (26; 68.4%) had zero docu-
mented infections or need for sinus-related antibiotics within
5 years of BCS. Only 4 (10.5%) children had subsequent epi-
sodes of acute sinusitis but did not meet failure criteria as their
disease was controlled with either single courses of antibiotics
or minimal medical management. Although we did not address
ethmoid disease intraoperatively, 9 (82%) patients with
additional ethmoid opacification with the maxillary sinus
disease on CT scan met success criteria following BCS. This
success rate was similar to patients who only had maxillary
sinus disease (21, 78%). No statistically significant data were
found relating failure criteria to age, gender, asthma, or
allergic rhinitis. Table 2 summarizes the statistical analysis
of these patients.
Discussion
In 2016, the International Consensus Statement on Allergy and
Rhinology (ICAR) released a clinical consensus statement for
the optimal diagnosis and management for pediatric CRS,
which followed up on the American Academy of Otolaryngol-
ogy (AAO) recommendations from 2014.2,11 Concerning first-
line therapy, the group determined that culture-directed
antibiotic therapy improves outcomes in patients who did not
respond to empiric antibiotic treatment.2 Long-term appropri-
ate antibiotic therapy and, in some situations, intravenous
antibiotics may be necessary.12 Nasal saline irrigations and
intranasal corticosteroid sprays are also first-line medical ther-
apy with documented benefits.11 Children who did not respond
to medical treatment might require alternative therapy.
Although asthma and/or allergic rhinitis may be strong contri-
butors to symptomology, negatively affecting up to 13% of
children,13 very few children will require surgical intervention
for their disease.
Adenoidectomy reached consensus by the AAO and ICAR
as an effective first-line surgical treatment for children up to 6
years with CRS and supported for kids up to 12 years of age.2,11
Although previous research has shown the independent effec-
tiveness of adenoidectomy varies among studies, the average
success rate typically settles around 50% of patients with
CRS.4,7 Adenoidectomy is recommended as a better surgical
intervention for a child with chronic adenoiditis without sinu-
sitis, especially in children younger than 13 years.2 When chil-
dren have chronic adenoiditis and CRS, the success rate of
adenoidectomy falls significantly.14 In such situations, FESS
is an effective procedure for the treatment of pediatric CRS
only after medical therapy and adenoidectomy have failed.2
Previous research suggests that BCS can offer an alternative
to FESS that is effective over short-term periods in addition to
being a less invasive operation comparatively.7,14 With BCS,
there is no sinonasal tissue removal compared to FESS, making
Table 1. Demographics and Clinical Characteristics of Pediatric
Patients With CRS.
Variable n %
Gender
Male 22 57.8
Female 16 42.2
Age, years, mean (SD)
Balloon sinuplasty 6.76 (2.27) -
FESS 7.02 (1.58) -
Time between BCS and FESS, years, mean (SD) 2.17 (1.44) -
Previous adenoidectomy 38 100.0
CT scan score (Lund-MacKay criteria)
All patients undergoing BCS, mean (SD) 8.63 (3.47) -
Failed BCS, mean (SD) 7.87 (2.45) -
Comorbid conditions at time of BCS
Allergic rhinitis 15 39.4
Asthma 13 34.2
Balloon sinuplasty side
Left maxillary sinus only 4 10.5
Right maxillary sinus only 2 5.3
Bilateral maxillary sinuses 32 84.2
Abbreviations: BCS, balloon catheter sinuplasty; CRS, chronic rhinosinusitis;
CT, computed tomography; FESS, functional endoscopic sinus surgery;
SD, standard deviation.
Table 2. Statistical Analysis for Balloon Sinuplasty Success in Pediatric
Patients With CRS.
Variable Success Group Failure Group P Value
Balloon sinuplasty, n (%) 30 (78.9) 8 (21.1) <.01a
Allergic rhinitis, % 40.0 37.5 .89
Asthma, % 33.3 37.5 .83
Males/females, % 53.3/47.7 75.0/25.0 .27
Age, mean (SD) 6.97 (2.25) 5.89 (2.41) .91
Abbreviations: CRS, chronic rhinosinusitis; SD, standard deviation.
aSignificance with binomial testing (null test statistic 0.99).
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the possibility of affecting facial development relatively low.
While the AAO did consider BCS for the treatment of pediatric
CRS, the consensus statement reached determined there was
insufficient evidence to compare BCS to FESS at the time of
publication.2 In addition, the panel did not reach consensus
regarding the effectiveness of balloon sinuplasty for the treat-
ment of pediatric CRS alone, but did reach near consensus for
its safety.2 In 2016, ICAR also did not give any consensus
regarding the role of BCS in the treatment to pediatric CRS
due to lack of robust evidence, especially long-term effective-
ness of this technology.11
Our research represents one of the first studies evaluating
the long-term effectiveness of BCS as an alternative step for
FESS in pediatric patients less than 13 years. Over a 3-year
period, 78.9% of patients who underwent BCS no longer
had recurrent or persistent sinus infections (5 infections
over 12 months), characterized by nasal obstruction, con-
gestion, yellow/green discharge, cough, headache, facial
pain/pressure, or need for antibiotics (P < .01). Based on
current guidelines, since all these patients presented to our
clinic following prior adenoidectomy and failed medical
management for CRS, FESS would have been viable alter-
native for treatment. By performing a BCS instead of FESS,
86.9% of our pediatric patients did not require any further
surgical intervention within 5 years of their balloon sinu-
plasty. Among those who met failure criteria, there was no
difference in their gender, age, asthma, or allergy status
(Table 2). If patients with any sinus symptoms or need for
antibiotics were included in our failure group, 68.4% of
children would still have benefited from balloon procedure
as they did not have any documented symptoms or antibio-
tic requirements within their medical chart.
Balloon catheter sinuplasty may not be suitable for some
children, as several patients were excluded from our study
due to underlying immunodeficiency. In addition, some
patients were not candidates for BCS, specifically those
who have hypoplastic maxillary sinuses or children with
significant ethmoid sinusitis from CT scan evaluation. Pre-
vious research found that children with a Lund-Mackay
score 5 are more likely to have CRS as opposed to allergic
sinusitis or adenoiditis, making children with Lund-Mackay
scores <5 also not suitable for our study.10,15 Therefore, the
choice of surgical intervention should be individualized for
every patient.
A significant limitation of this study, however, was the
retrospective nature of data accumulation. Because no objec-
tive or validated study was utilized at the time of CRS diag-
nosis to determine symptom recurrence, documentation of
sinus disease was entirely from subjective medical notation.
In addition, as this is a 1-arm retrospective study with no
comparison to other treatment modalities, BCS as a compara-
tive therapy cannot be analyzed. However, as mentioned pre-
viously, this patient population would otherwise have
undergone endoscopic surgery due to previously failed man-
agement of CRS. In addition, as this is a pediatric patient
population, it is plausible that sinus development allowed
some patients to ‘‘grow out’’ of their disease rather than direct
effect from the BCS.
Balloon catheter sinuplasty is an effective long-term alter-
native for the treatment of CRS in pediatric patients who con-
tinue to have infections following adenoidectomy and medical
management. For parents hoping to avoid further infections and
eventual endoscopic surgery in their children, BCS is a viable
solution in selected cases due to its efficacy and well-
established safety profile compared to FESS. Further studies,
particularly a prospective randomized trial comparing balloon
sinuplasty to endoscopic surgery following adenoidectomy,
would be important to evaluate in the future based on recent
clinical guidelines.
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